Verastem (VSTM) Receivables - Other (2011 - 2016)
Verastem's (VSTM) quarterly Receivables - Other came in at $204000.0 in Q4 2016, up 32.47% year-on-year from $154000.0 in Q1 2016, and up 32.47% quarter-over-quarter from $154000.0 in Q4 2015.
Verastem (VSTM) Receivables - Other (2011 - 2016) Analysis & Trends
Verastem's Receivables - Other history runs 6 years deep, the most recent figure standing at $204000.0 for Q4 2016.
- On a quarterly basis, Receivables - Other rose 32.47% year-over-year to $204000.0 in Q4 2016; TTM through Dec 2016 was $204000.0, a 32.47% increase from a year earlier, with the FY2016 full-year figure at $204000.0, up 32.47% from the prior year.
- Receivables - Other rose to $204000.0 in Q4 2016 per VSTM's latest filing, from $154000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $204000.0 in Q4 2016 and bottomed at $113000.0 in Q4 2014.
- The 5-year median for Receivables - Other is $133000.0 (2012), against an average of $144714.3.
- Across the five-year window, Receivables - Other surged 203.77% in 2012 and declined 23.6% in 2013, its largest moves.
- Year by year, Receivables - Other stood at $161000.0 in 2012, then retreated by 23.6% to $123000.0 in 2013, then decreased by 8.13% to $113000.0 in 2014, then jumped by 36.28% to $154000.0 in 2015, then soared by 32.47% to $204000.0 in 2016.
- Per Business Quant, the three latest VSTM Receivables - Other figures stand at $204000.0 (Q4 2016), $154000.0 (Q4 2015), and $113000.0 (Q4 2014).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Verastem | 166.09 Mn | -31.73 Mn | 15.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 204,000.00 |
| Dec 31, 2016 | 204,000.00 |
| Dec 31, 2015 | 154,000.00 |
| Dec 31, 2015 | 154,000.00 |
| Dec 31, 2014 | 113,000.00 |
| Dec 31, 2014 | 113,000.00 |
| Dec 31, 2013 | 123,000.00 |
| Dec 31, 2013 | 123,000.00 |
| Dec 31, 2012 | 161,000.00 |
| Dec 31, 2012 | 161,000.00 |
| Sep 30, 2012 | 125,000.00 |
| Sep 30, 2012 | 125,000.00 |
| Jun 30, 2012 | 133,000.00 |
| Jun 30, 2012 | 133,000.00 |
| Dec 31, 2011 | 53,000.00 |
| Dec 31, 2011 | 53,000.00 |